Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × CD2-associated protein × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1

Interventions

Specimen Handling 427 pembrolizumab 420 Magnetic Resonance Spectroscopy 368 Carboplatin 300 Cyclophosphamide 269 Cisplatin 253 Biopsy 237 Radiotherapy 213 Paclitaxel 197 Gemcitabine 197 Bevacizumab 185 Nivolumab 170 venetoclax 166 fludarabine 156 Drug Therapy 145 Blood Specimen Collection 144 Dexamethasone 138 Docetaxel 134 Oxaliplatin 133 Injections 133 Fluorouracil 131 Capecitabine 131 Radiosurgery 122 Rituximab 121 Standard of Care 118 Pemetrexed 114 atezolizumab 104 durvalumab 100 Radiation 100 Doxorubicin 96

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07478016 2026-03-17

EXIST

Thomas Jefferson University

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡